William Ashton Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William Ashton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William Ashton. William Ashton is Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Galena Biopharma, Inc. ($GALE) and Director in Recro Pharma, Inc. ($REPH) and Director in Baudax Bio, Inc. ($BXRX).
Latest Insider Trading Transactions of William Ashton
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXRX, REPH, SLS, SPPI, SCMP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
Apr 22 2021 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 26,923 | 0 | 80,280 | 53.4 K to 80.3 K (+50.46 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 56,452 | 0 | 107,185 | 50.7 K to 107.2 K (+111.27 %) |
Jun 23 2020 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 2.94 | 60,000 | 176,400 | 60,000 | |
Jun 23 2020 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Sell | S | 3.25 | 5,000 | 16,250 | 41,666 | 46.7 K to 41.7 K (-10.71 %) |
Jun 19 2020 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 2.94 | 60,000 | 176,400 | 60,000 | |
Jun 19 2020 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Grant | A | 0.00 | 30,000 | 0 | 46,666 | 16.7 K to 46.7 K (+180.01 %) |
Jun 19 2020 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 2.94 | 60,000 | 176,400 | 60,000 | |
Jun 19 2020 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Grant | A | 0.00 | 30,000 | 0 | 46,666 | 16.7 K to 46.7 K (+180.01 %) |
May 11 2020 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
May 11 2020 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 8,363 | 0 | 53,357 | 45 K to 53.4 K (+18.59 %) |
May 08 2020 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Option Exercise | A | 3.05 | 34,574 | 105,451 | 34,574 | |
May 08 2020 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 22,951 | 0 | 50,733 | 27.8 K to 50.7 K (+82.61 %) |
Dec 09 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 17,582 | 0 | 44,994 | 27.4 K to 45 K (+64.14 %) |
Dec 09 2019 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 20,000 | 0 | 27,782 | 7.8 K to 27.8 K (+257.00 %) |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 8.44 | 20,000 | 168,800 | 20,000 | |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Grant | A | 0.00 | 10,000 | 0 | 16,666 | 6.7 K to 16.7 K (+150.02 %) |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Sell | S | 8.50 | 1,667 | 14,170 | 6,666 | 8.3 K to 6.7 K (-20.00 %) |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Sell | S | 8.59 | 5,000 | 42,950 | 8,333 | 13.3 K to 8.3 K (-37.50 %) |
May 10 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
May 10 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 7,955 | 0 | 27,412 | 19.5 K to 27.4 K (+40.89 %) |
Dec 03 2018 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 14.02 | 6,667 | 93,471 | 6,667 | |
Dec 03 2018 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 14.02 | 6,667 | 93,471 | 6,667 | |
Dec 03 2018 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Grant | A | 0.00 | 3,333 | 0 | 13,333 | 10 K to 13.3 K (+33.33 %) |
Dec 03 2018 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Grant | A | 0.00 | 3,333 | 0 | 13,333 | 10 K to 13.3 K (+33.33 %) |
Jun 19 2018 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Option Exercise | A | 19.95 | 20,000 | 399,000 | 20,000 | |
Jun 19 2018 | SPPI | SPECTRUM PHARMACEU ... | Ashton William | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
May 14 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
May 14 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Buy | M | 0.00 | 13,274 | 0 | 19,457 | 6.2 K to 19.5 K (+214.69 %) |
May 08 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
May 08 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
Oct 10 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 0.38 | 15,472 | 5,879 | 38,154 | 22.7 K to 38.2 K (+68.21 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 0.59 | 9,866 | 5,821 | 22,682 | 12.8 K to 22.7 K (+76.98 %) |
May 16 2017 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
Apr 12 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 0.59 | 9,870 | 5,823 | 12,816 | 2.9 K to 12.8 K (+335.03 %) |
Jan 24 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 1.98 | 2,946 | 5,833 | 2,946 | 0 to 2.9 K |
Jul 18 2016 | GALE | Galena Biopharma, ... | Ashton William | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Dec 18 2015 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Ashton William | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 6.80 | 16,666 | 113,329 | 10,234 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 8.62 | 20,000 | 172,400 | 26,900 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 7.71 | 19,096 | 147,230 | 46,900 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 7.71 | 904 | 6,970 | 65,996 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 4.41 | 13,500 | 59,535 | 66,900 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 4.41 | 9,600 | 42,336 | 80,400 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 3.56 | 20,000 | 71,200 | 90,000 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | M | 4.99 | 30,000 | 149,700 | 110,000 | |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.55 | 16,666 | 292,488 | 0 | 16.7 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 6.80 | 16,666 | 113,329 | 16,666 | 0 to 16.7 K |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.55 | 20,000 | 351,000 | 0 | 20 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 8.62 | 20,000 | 172,400 | 20,000 | 0 to 20 K |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.55 | 19,096 | 335,135 | 0 | 19.1 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 7.71 | 19,096 | 147,230 | 19,096 | 0 to 19.1 K |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.32 | 904 | 15,657 | 0 | 904 to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 7.71 | 904 | 6,970 | 904 | 0 to 904 |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.32 | 13,500 | 233,820 | 0 | 13.5 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 4.41 | 13,500 | 59,535 | 13,500 | 0 to 13.5 K |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.32 | 9,600 | 166,272 | 0 | 9.6 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 4.41 | 9,600 | 42,336 | 9,600 | 0 to 9.6 K |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.32 | 20,000 | 346,400 | 0 | 20 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 3.56 | 20,000 | 71,200 | 20,000 | 0 to 20 K |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Sell | S | 17.32 | 30,000 | 519,600 | 0 | 30 K to 0 (-100.00 %) |
Mar 18 2015 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Buy | M | 4.99 | 30,000 | 149,700 | 30,000 | 0 to 30 K |
Oct 19 2009 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | A | 4.99 | 30,000 | 149,700 | 30,000 |
Page: 1